Cross Country Healthcare merger with Aya Healthcare terminated; to receive $20M fee; starts buybacks

CROSS COUNTRY HEALTHCARE INC

Merger agreement with Aya Healthcare terminated effective Dec 4, 2025 after failing to close by Dec 3, 2025 end date.
Aya to pay Cross Country a $20 million termination fee within two business days.
Termination due to FTC review not completed; HSR waiting period extended to Dec 30, 2025 because of 43-day government shutdown.
Company to immediately commence share repurchases under existing $40 million authorization.
Company reports no debt and strong cash position; refocuses on standalone strategy.

item 1.02 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0000950103-25-015716
form_type: 8-K
ticker: CCRN
cik: 0001141103
company_name: CROSS COUNTRY HEALTHCARE INC
filed_at: 2025-12-04T23:59:59+00:00
discovered_at: 2026-05-14T18:02:38.880970+00:00
generated_at: 2026-05-16T14:30:32.613513+00:00
sec_items: ["1.02", "7.01", "9.01"]
event_type: other_material
sentiment: negative
materiality_score: 0.8
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0000950103-25-015716
json_url: https://secwatch.observer/filing/0000950103-25-015716.json
markdown_url: https://secwatch.observer/filing/0000950103-25-015716.md
text_url: https://secwatch.observer/filing/0000950103-25-015716.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1141103/000095010325015716/0000950103-25-015716-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1141103/000095010325015716/dp238334_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0000950103-25-015716

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.